Synthetic Cannabinoids and ST-Elevated Myocardial Infarction: A Case Report and Literature Review
Hassaan Iftikhar1,2,3, Maryam Saleem1,3,4, Hafiz S Naeem2
1Nephrology, Ohio Valley Nephrology Associates, Owensboro, USA.
Abstract:
The use of synthetic cannabinoids and marijuana has been known to be associated with myocardial infarction and coronary vasospasms according to a few case reports published for the pediatric population. The data on the use of synthetic cannabinoids and myocardial infarction in adults however is limited. The adverse effects of these so-called designer drugs have been far-reaching. Here, we describe a case of an adult male with ST-elevated myocardial infarction diagnosed secondary to smoking synthetic cannabinoids.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Myocarditis III: Medical Management
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Myocarditis I: Introduction


